Skip to content

Denileukin Diftitox

Published: July 26, 2026Updated: July 26, 2026

Denileukin diftitox is a targeted fusion protein therapy that delivers the cytocidal portion of diphtheria toxin directly to cells expressing the IL-2 receptor. It is primarily used to treat certain blood cancers and skin conditions involving abnormal T-cell proliferation with IL-2 receptor expression.

Quick summary

A targeted cancer therapy that uses diphtheria toxin to kill cells expressing the IL-2 receptor.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
L01XX29
RxNorm
214470
Generic
Denileukin Diftitox
Class
atc-l01
Brands
Lymphir
Availability
rx
Lactation
unknown
Routes
—
Forms
injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Primarily indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in patients whose malignant T-cells express the CD25 component of the IL-2 receptor. May be considered in other hematologic malignancies expressing IL-2 receptors.

Denileukin diftitox is a fusion protein combining IL-2 with diphtheria toxin fragments. It binds specifically to cells expressing IL-2 receptors (CD25), undergoes internalization, and releases diphtheria toxin fragments that inhibit protein synthesis, leading to targeted cell death.

Administered via intravenous infusion by healthcare professionals experienced in chemotherapy. Common adverse effects include capillary leak syndrome, flu-like symptoms, and gastrointestinal disturbances. Pre-existing antibodies to diphtheria toxin may reduce efficacy. Requires careful monitoring of fluid status, kidney function, and vital signs during treatment.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy